Developing Wound Dressings Using 2-deoxy-<i>D</i>-Ribose to Induce Angiogenesis as a Backdoor Route for Stimulating the Production of Vascular Endothelial Growth Factor

2-deoxy-<i>D</i>-Ribose (2dDR) was first identified in 1930 in the structure of DNA and discovered as a degradation product of it later when the enzyme thymidine phosphorylase breaks down thymidine into thymine. In 2017, our research group explored the development of wound dressings base...

Full description

Bibliographic Details
Main Authors: Serkan Dikici, Muhammad Yar, Anthony J. Bullock, Joanna Shepherd, Sabiniano Roman, Sheila MacNeil
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/21/11437
_version_ 1797512534720249856
author Serkan Dikici
Muhammad Yar
Anthony J. Bullock
Joanna Shepherd
Sabiniano Roman
Sheila MacNeil
author_facet Serkan Dikici
Muhammad Yar
Anthony J. Bullock
Joanna Shepherd
Sabiniano Roman
Sheila MacNeil
author_sort Serkan Dikici
collection DOAJ
description 2-deoxy-<i>D</i>-Ribose (2dDR) was first identified in 1930 in the structure of DNA and discovered as a degradation product of it later when the enzyme thymidine phosphorylase breaks down thymidine into thymine. In 2017, our research group explored the development of wound dressings based on the delivery of this sugar to induce angiogenesis in chronic wounds. In this review, we will survey the small volume of conflicting literature on this and related sugars, some of which are reported to be anti-angiogenic. We review the evidence of 2dDR having the ability to stimulate a range of pro-angiogenic activities in vitro and in a chick pro-angiogenic bioassay and to stimulate new blood vessel formation and wound healing in normal and diabetic rat models. The biological actions of 2dDR were found to be 80 to 100% as effective as VEGF in addition to upregulating the production of VEGF. We then demonstrated the uptake and delivery of the sugar from a range of experimental and commercial dressings. In conclusion, its pro-angiogenic properties combined with its improved stability on storage compared to VEGF, its low cost, and ease of incorporation into a range of established wound dressings make 2dDR an attractive alternative to VEGF for wound dressing development.
first_indexed 2024-03-10T06:03:11Z
format Article
id doaj.art-f2da64020fa24606898dc0f3d4c42d83
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T06:03:11Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-f2da64020fa24606898dc0f3d4c42d832023-11-22T20:52:10ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-10-0122211143710.3390/ijms222111437Developing Wound Dressings Using 2-deoxy-<i>D</i>-Ribose to Induce Angiogenesis as a Backdoor Route for Stimulating the Production of Vascular Endothelial Growth FactorSerkan Dikici0Muhammad Yar1Anthony J. Bullock2Joanna Shepherd3Sabiniano Roman4Sheila MacNeil5Department of Bioengineering, Izmir Institute of Technology, 35430 Izmir, TurkeyInterdisciplinary Research Centre in Biomedical Materials (IRCBM), COMSATS University Islamabad, Lahore Campus, Lahore 54000, PakistanDepartment of Materials Science & Engineering, Kroto Research Institute, University of Sheffield, Sheffield S3 7HQ, UKSchool of Clinical Dentistry, University of Sheffield, Sheffield S10 2TA, UKDepartment of Materials Science & Engineering, Kroto Research Institute, University of Sheffield, Sheffield S3 7HQ, UKDepartment of Materials Science & Engineering, Kroto Research Institute, University of Sheffield, Sheffield S3 7HQ, UK2-deoxy-<i>D</i>-Ribose (2dDR) was first identified in 1930 in the structure of DNA and discovered as a degradation product of it later when the enzyme thymidine phosphorylase breaks down thymidine into thymine. In 2017, our research group explored the development of wound dressings based on the delivery of this sugar to induce angiogenesis in chronic wounds. In this review, we will survey the small volume of conflicting literature on this and related sugars, some of which are reported to be anti-angiogenic. We review the evidence of 2dDR having the ability to stimulate a range of pro-angiogenic activities in vitro and in a chick pro-angiogenic bioassay and to stimulate new blood vessel formation and wound healing in normal and diabetic rat models. The biological actions of 2dDR were found to be 80 to 100% as effective as VEGF in addition to upregulating the production of VEGF. We then demonstrated the uptake and delivery of the sugar from a range of experimental and commercial dressings. In conclusion, its pro-angiogenic properties combined with its improved stability on storage compared to VEGF, its low cost, and ease of incorporation into a range of established wound dressings make 2dDR an attractive alternative to VEGF for wound dressing development.https://www.mdpi.com/1422-0067/22/21/114372-deoxy-<i>D</i>-Ribose (2dDR)deoxy sugarangiogenesiswound healingchronic woundswound dressing
spellingShingle Serkan Dikici
Muhammad Yar
Anthony J. Bullock
Joanna Shepherd
Sabiniano Roman
Sheila MacNeil
Developing Wound Dressings Using 2-deoxy-<i>D</i>-Ribose to Induce Angiogenesis as a Backdoor Route for Stimulating the Production of Vascular Endothelial Growth Factor
International Journal of Molecular Sciences
2-deoxy-<i>D</i>-Ribose (2dDR)
deoxy sugar
angiogenesis
wound healing
chronic wounds
wound dressing
title Developing Wound Dressings Using 2-deoxy-<i>D</i>-Ribose to Induce Angiogenesis as a Backdoor Route for Stimulating the Production of Vascular Endothelial Growth Factor
title_full Developing Wound Dressings Using 2-deoxy-<i>D</i>-Ribose to Induce Angiogenesis as a Backdoor Route for Stimulating the Production of Vascular Endothelial Growth Factor
title_fullStr Developing Wound Dressings Using 2-deoxy-<i>D</i>-Ribose to Induce Angiogenesis as a Backdoor Route for Stimulating the Production of Vascular Endothelial Growth Factor
title_full_unstemmed Developing Wound Dressings Using 2-deoxy-<i>D</i>-Ribose to Induce Angiogenesis as a Backdoor Route for Stimulating the Production of Vascular Endothelial Growth Factor
title_short Developing Wound Dressings Using 2-deoxy-<i>D</i>-Ribose to Induce Angiogenesis as a Backdoor Route for Stimulating the Production of Vascular Endothelial Growth Factor
title_sort developing wound dressings using 2 deoxy i d i ribose to induce angiogenesis as a backdoor route for stimulating the production of vascular endothelial growth factor
topic 2-deoxy-<i>D</i>-Ribose (2dDR)
deoxy sugar
angiogenesis
wound healing
chronic wounds
wound dressing
url https://www.mdpi.com/1422-0067/22/21/11437
work_keys_str_mv AT serkandikici developingwounddressingsusing2deoxyidiribosetoinduceangiogenesisasabackdoorrouteforstimulatingtheproductionofvascularendothelialgrowthfactor
AT muhammadyar developingwounddressingsusing2deoxyidiribosetoinduceangiogenesisasabackdoorrouteforstimulatingtheproductionofvascularendothelialgrowthfactor
AT anthonyjbullock developingwounddressingsusing2deoxyidiribosetoinduceangiogenesisasabackdoorrouteforstimulatingtheproductionofvascularendothelialgrowthfactor
AT joannashepherd developingwounddressingsusing2deoxyidiribosetoinduceangiogenesisasabackdoorrouteforstimulatingtheproductionofvascularendothelialgrowthfactor
AT sabinianoroman developingwounddressingsusing2deoxyidiribosetoinduceangiogenesisasabackdoorrouteforstimulatingtheproductionofvascularendothelialgrowthfactor
AT sheilamacneil developingwounddressingsusing2deoxyidiribosetoinduceangiogenesisasabackdoorrouteforstimulatingtheproductionofvascularendothelialgrowthfactor